Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
Apply
Sacituzumab & Pembrolizumab
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step